Selected research
Industry Research
Rosuvastatin Calcium Drug Industry Research Report 2026
Market perspective
The global Rosuvastatin Calcium Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Rosuvastatin Calcium Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Rosuvastatin Calcium Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Rosuvastatin Calcium Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Rosuvastatin Calcium Drug include Accord Healthcare, Actavis Pharma, Angita Pharma, A-S Medication Solutions, AstraZeneca Pharmaceuticals, PD-Rx Pharmaceuticals, Hisun Pharmaceutical, Jinan Jinda and Jingxin Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Rosuvastatin Calcium Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rosuvastatin Calcium Drug Market by Company
Accord Healthcare
Actavis Pharma
Angita Pharma
A-S Medication Solutions
AstraZeneca Pharmaceuticals
PD-Rx Pharmaceuticals
Hisun Pharmaceutical
Jinan Jinda
Jingxin Pharmaceutical
Lunan Pharmaceutical Group
Sandoz
Chia-Tai Tianqing Pharmaceutical
Rosuvastatin Calcium Drug Segment by Type
Capsules
Tablets
Rosuvastatin Calcium Drug Segment by Application
Clinics
Hospitals
Others
Rosuvastatin Calcium Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin Calcium Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin Calcium Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin Calcium Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rosuvastatin Calcium Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rosuvastatin Calcium Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rosuvastatin Calcium Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsules
- Tablets
Applications
- Clinics
- Hospitals
- Others
Companies covered
- Accord Healthcare
- Actavis Pharma
- Angita Pharma
- A-S Medication Solutions
- AstraZeneca Pharmaceuticals
- PD-Rx Pharmaceuticals
- Hisun Pharmaceutical
- Jinan Jinda
- Jingxin Pharmaceutical
- Lunan Pharmaceutical Group
- Sandoz
- Chia-Tai Tianqing Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rosuvastatin Calcium Drug Market Size (2021-2032)
- 2.2.2 Global Rosuvastatin Calcium Drug Sales (2021-2032)
- 2.2.3 Global Rosuvastatin Calcium Drug Market Average Price (2021-2032)
- 2.3 Rosuvastatin Calcium Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsules
- 2.3.3 Tablets
- 2.4 Rosuvastatin Calcium Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinics
- 2.4.3 Hospitals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rosuvastatin Calcium Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rosuvastatin Calcium Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Rosuvastatin Calcium Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Rosuvastatin Calcium Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Rosuvastatin Calcium Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rosuvastatin Calcium Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rosuvastatin Calcium Drug, Product Type & Application
- 3.8 Global Manufacturers of Rosuvastatin Calcium Drug, Established Date
- 3.9 Global Rosuvastatin Calcium Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Healthcare
- 4.1.1 Accord Healthcare Company Information
- 4.1.2 Accord Healthcare Business Overview
- 4.1.3 Accord Healthcare Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Healthcare Rosuvastatin Calcium Drug Product Portfolio
- 4.1.5 Accord Healthcare Recent Developments
- 4.2 Actavis Pharma
- 4.2.1 Actavis Pharma Company Information
- 4.2.2 Actavis Pharma Business Overview
- 4.2.3 Actavis Pharma Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Actavis Pharma Rosuvastatin Calcium Drug Product Portfolio
- 4.2.5 Actavis Pharma Recent Developments
- 4.3 Angita Pharma
- 4.3.1 Angita Pharma Company Information
- 4.3.2 Angita Pharma Business Overview
- 4.3.3 Angita Pharma Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Angita Pharma Rosuvastatin Calcium Drug Product Portfolio
- 4.3.5 Angita Pharma Recent Developments
- 4.4 A-S Medication Solutions
- 4.4.1 A-S Medication Solutions Company Information
- 4.4.2 A-S Medication Solutions Business Overview
- 4.4.3 A-S Medication Solutions Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 A-S Medication Solutions Rosuvastatin Calcium Drug Product Portfolio
- 4.4.5 A-S Medication Solutions Recent Developments
- 4.5 AstraZeneca Pharmaceuticals
- 4.5.1 AstraZeneca Pharmaceuticals Company Information
- 4.5.2 AstraZeneca Pharmaceuticals Business Overview
- 4.5.3 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AstraZeneca Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 4.5.5 AstraZeneca Pharmaceuticals Recent Developments
- 4.6 PD-Rx Pharmaceuticals
- 4.6.1 PD-Rx Pharmaceuticals Company Information
- 4.6.2 PD-Rx Pharmaceuticals Business Overview
- 4.6.3 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 PD-Rx Pharmaceuticals Rosuvastatin Calcium Drug Product Portfolio
- 4.6.5 PD-Rx Pharmaceuticals Recent Developments
- 4.7 Hisun Pharmaceutical
- 4.7.1 Hisun Pharmaceutical Company Information
- 4.7.2 Hisun Pharmaceutical Business Overview
- 4.7.3 Hisun Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hisun Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 4.7.5 Hisun Pharmaceutical Recent Developments
- 4.8 Jinan Jinda
- 4.8.1 Jinan Jinda Company Information
- 4.8.2 Jinan Jinda Business Overview
- 4.8.3 Jinan Jinda Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Jinan Jinda Rosuvastatin Calcium Drug Product Portfolio
- 4.8.5 Jinan Jinda Recent Developments
- 4.9 Jingxin Pharmaceutical
- 4.9.1 Jingxin Pharmaceutical Company Information
- 4.9.2 Jingxin Pharmaceutical Business Overview
- 4.9.3 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Jingxin Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 4.9.5 Jingxin Pharmaceutical Recent Developments
- 4.10 Lunan Pharmaceutical Group
- 4.10.1 Lunan Pharmaceutical Group Company Information
- 4.10.2 Lunan Pharmaceutical Group Business Overview
- 4.10.3 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Lunan Pharmaceutical Group Rosuvastatin Calcium Drug Product Portfolio
- 4.10.5 Lunan Pharmaceutical Group Recent Developments
- 4.11 Sandoz
- 4.11.1 Sandoz Company Information
- 4.11.2 Sandoz Business Overview
- 4.11.3 Sandoz Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Sandoz Rosuvastatin Calcium Drug Product Portfolio
- 4.11.5 Sandoz Recent Developments
- 4.12 Chia-Tai Tianqing Pharmaceutical
- 4.12.1 Chia-Tai Tianqing Pharmaceutical Company Information
- 4.12.2 Chia-Tai Tianqing Pharmaceutical Business Overview
- 4.12.3 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Chia-Tai Tianqing Pharmaceutical Rosuvastatin Calcium Drug Product Portfolio
- 4.12.5 Chia-Tai Tianqing Pharmaceutical Recent Developments
5 Global Rosuvastatin Calcium Drug Market Scenario by Region
- 5.1 Global Rosuvastatin Calcium Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rosuvastatin Calcium Drug Sales by Region: 2021-2032
- 5.2.1 Global Rosuvastatin Calcium Drug Sales by Region: 2021-2026
- 5.2.2 Global Rosuvastatin Calcium Drug Sales by Region: 2027-2032
- 5.3 Global Rosuvastatin Calcium Drug Revenue by Region: 2021-2032
- 5.3.1 Global Rosuvastatin Calcium Drug Revenue by Region: 2021-2026
- 5.3.2 Global Rosuvastatin Calcium Drug Revenue by Region: 2027-2032
- 5.4 North America Rosuvastatin Calcium Drug Market Facts & Figures by Country
- 5.4.1 North America Rosuvastatin Calcium Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 5.4.3 North America Rosuvastatin Calcium Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rosuvastatin Calcium Drug Market Facts & Figures by Country
- 5.5.1 Europe Rosuvastatin Calcium Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 5.5.3 Europe Rosuvastatin Calcium Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rosuvastatin Calcium Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rosuvastatin Calcium Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rosuvastatin Calcium Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rosuvastatin Calcium Drug Market Facts & Figures by Country
- 5.7.1 South America Rosuvastatin Calcium Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 5.7.3 South America Rosuvastatin Calcium Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Rosuvastatin Calcium Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rosuvastatin Calcium Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rosuvastatin Calcium Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rosuvastatin Calcium Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rosuvastatin Calcium Drug Sales by Type (2021-2032)
- 6.1.1 Global Rosuvastatin Calcium Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Rosuvastatin Calcium Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Rosuvastatin Calcium Drug Revenue by Type (2021-2032)
- 6.2.1 Global Rosuvastatin Calcium Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rosuvastatin Calcium Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Rosuvastatin Calcium Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rosuvastatin Calcium Drug Sales by Application (2021-2032)
- 7.1.1 Global Rosuvastatin Calcium Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Rosuvastatin Calcium Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Rosuvastatin Calcium Drug Revenue by Application (2021-2032)
- 7.2.1 Global Rosuvastatin Calcium Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rosuvastatin Calcium Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Rosuvastatin Calcium Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rosuvastatin Calcium Drug Value Chain Analysis
- 8.1.1 Rosuvastatin Calcium Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rosuvastatin Calcium Drug Production Mode & Process
- 8.2 Rosuvastatin Calcium Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rosuvastatin Calcium Drug Distributors
- 8.2.3 Rosuvastatin Calcium Drug Customers
9 Global Rosuvastatin Calcium Drug Analyzing Market Dynamics
- 9.1 Rosuvastatin Calcium Drug Industry Trends
- 9.2 Rosuvastatin Calcium Drug Industry Drivers
- 9.3 Rosuvastatin Calcium Drug Industry Opportunities and Challenges
- 9.4 Rosuvastatin Calcium Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst